Evidence map›Paper›PMID 37189590›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure.

Tuukka Helin, Tomi Tirri, Heidi Korkala, Kimmo Lappalainen, Lotta Joutsi-Korhonen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tuukka HelinDepartment of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, P.O. Box 720, 00029 Helsinki, Finland.ORCID 0000-0002-5273-8088
Tomi TirriDepartment of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, P.O. Box 720, 00029 Helsinki, Finland.
Heidi KorkalaDepartment of Radiology, HUS Diagnostic Center, Helsinki University Hospital, P.O. Box 320, 00029 Helsinki, Finland.
Kimmo LappalainenDepartment of Radiology, HUS Diagnostic Center, Helsinki University Hospital, P.O. Box 320, 00029 Helsinki, Finland.
Lotta Joutsi-KorhonenDepartment of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, P.O. Box 720, 00029 Helsinki, Finland.ORCID 0000-0002-7355-2354
University of Helsinki · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activated clotting time (ACT) is used in cardiac surgery for monitoring unfractionated heparin (UFH). In endovascular radiology, ACT use is less established. We aimed to test the validity of ACT in UFH monitoring in endovascular radiology. We recruited 15 patients undergoing endovascular radiologic procedure. ACT was measured with ICT Hemochron

Indexed as

activated clotting timeanti-Xaendovascularinterventional radiologyunfractionated heparin

Identifiers

PMID37189590
PMCPMC10137659
OpenAlexW4366772972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.